WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells

Pathobiology

Volumn 80, Issue 5, 2013, Pages 235-244

  Kanzawa, Maki ^a   Semba, Shuho ^a   Hara, Shigeo ^a   Itoh, Tomoo ^a   Yokozaki, Hiroshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer stem cells; CD133; Epithelial mesenchymal transition; Gastric carcinoma; SNAI1; WNT5A

Indexed keywords

CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; MESSENGER RNA; WNT5A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CANCER TISSUE; CARCINOGENICITY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FOCAL ADHESION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; TUMOR MICROENVIRONMENT; UPREGULATION;

LENTIVIRUS;

EID: 84876457158     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000346843     Document Type: Article

References (37)

1. Cunha GR, Hayward SW, Wang YZ, Ricke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 2003; 107:1-10.
2. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59:5002-5011.
3. Nishimura K, Semba S, Aoyagi K, Sasaki H, Yokozaki H: Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells. Patho-biology 2012; 79:290-306.
4. Logan CY, Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20:781-810.
5. Nishita M, Yoo SK, Nomachi A, Kani S, Sou-gawa N, Ohta Y, Takada S, Kikuchi A, Mina-mi Y: Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wn-t5a-induced cell migration. J Cell Biol 2006; 175:555-562.
6. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W, Kikuchi A: Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006; 66:10439-10448.
7. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Oka-da M, Takumi T, Nishita M, Minami Y: Autonomous regulation of osteosarcoma cell in-vasiveness by Wnt5a/Ror2 signaling. Onco-gene 2009; 28:3197-3208.
8. Yamamoto H, Kitadai Y, Oue N, Ohdan H, Yasui W, Kikuchi A: Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells. Gastroenterology 2009; 137:242-252.
9. Ann EJ, Kim HY, Seo MS, Mo JS, Kim MY, Yoon JH, Ahn JS, Park HS: Wnt5a controls Notch1 signaling through CaMKII mediated degradation of the SMRT corepressor protein. J Biol Chem 2012; 287: 36814-36829.
10. Grudzien P, Lo S, Albain KS, Robinson P, Ra-jan P, Strack PR, Golde TE, Miele L, Foreman KE: Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. An-ticancer Res 2010; 30:3853-3867.
11. Singh A, Settleman J: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29:4741-4751.
12. Campbell LL, Polyak K: Breast tumor heterogeneity: cancer stem cell or clonal evolution? Cell Cycle 2007; 6:2332-2338.
13. Clarke MF, Fuller M: Stem cells and cancer: two faces of eve. Cell 2006; 124:1111-1115.
14. Polyak K, Hahn WC: Roots and stems: stem cells in cancer. Nat Med 2006; 12:296-300.
15. Singh SK, Hawkins C, Clarke ID, Squire JA, Bay-ani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
16. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445:106-110.
17. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132: 2542-2556.
18. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H: Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 2007; 6:92-97.
19. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT: The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 2008; 68:9703-9711.
20. Yin AH, Miraglia S, Zanjani ED, Almeida-Po-rada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90:5002-5012.
21. Bidlingmaier S, Zhu X, Liu B: The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008; 86:1025-1032.
22. Hojo H: Establishment of cultured cell lines of human stomach cancer-origin and their morphological characteristics (in Japanese). Ni-igata Igakukai Zassi 1977; 91:737-752.
23. Motoyama T, Hojo H, Watanabe H: Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 1986; 36: 65-83.
24. Yanagihara K, Ito A, Toge T, Numoto M: An-tiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993; 53:5815-5821.
25. Yanagihara K, Seyama T, Tsumuraya M, Ka-mada N, Yokoro K: Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 1991; 51:381-386.
26. Ochiai A, Yasui W, Tahara E: Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 1985; 76:1064-1071.
27. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1998; 1:10-24.
28. Vaiopoulos AG, Kostakis ID, Koutsilieris M, Papavassiliou AG: Colon cancer stem cells. Stem Cells 2012; 30:363-371.
29. Brablets S, Schmalhofer O, Brablets T: Gastrointestinal stem cells in development and cancer. J Pathol 2009; 217:307-317.
30. Tetsu O, McCormick F: β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398:422-426.
31. Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Roder-mond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-476.
32. Voon DC, Wang H, Koo JK, Nguyen TA, Hor YT, Chu YS, Ito K, Fukamachi H, Chan L, Thiery JP, Ito Y: Runx3 protects gastric epithelial cell against epithelial-mesenchymal transition-induced cellular plasticity and tu-morigenicity. Stem Cells 2012; 30:2088-2099.
33. Ikenouchi J, Matsuda M, Furse M, Tsukita S: Regulation of tight junction during the epithe-lium-mesenchyme transition: direct repression of gene expression of claudins/occludin by Snail. J Cell Sci 2003; 116:1959-1967.
34. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KL, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, Weeraratna AT: The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 2007; 282:17259-17271.
35. Ikushima H, Todo T, Ino Y, Takahashi M, Mi-yazawa M, Miyazono K: Autocrine TGF-β signaling maintains tumorigenicity of glio-ma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 2009; 5:504-514.
36. Yusra, Semba S, Yokozaki H: Biological significance of tumor budding at the invasive front of human colorectal carcinoma cells. Int J Oncol 2012; 41:201-210.
37. Floor S, van Staveren WC, Larsimont D, Du-mont JE, Maenhaut C: Cancer cells in epithe-lial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations. Oncogene 2011; 30:4609-4621.